A Case of Erythroderma Secondary to HypereosinophiliaCorrespondence Address :
Dr. Prabu Pandurangan,
Consultant Haematologist, Department of Haematology, Greams Road, Apollo Main Hospital, Chennai, Tamil Nadu, India.
Hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterised by marked peripheral eosinophilia and end organ damage attributable to eosinophilia without secondary cause. Early recognition and treatment are essential to prevent morbidity and mortality. Cytoreduction with Steroids, Hydroxyurea and Imatinib are the main stay of treatment. Molecular studies like Fip1-like-1 fused with platelet derived growth factor receptor alpha (FIP1L1-PDGFRa) etc., are recommended in view of therapeutic implication. In this paper we report a rare case of HES developing in a lady 6 months after surgical removal of lymphangioma of spleen, which in itself is rare.
Adrenal insufficiency, Cytoreduction, Lymphangioma of spleen, Tissue eosinophilia
Mohammed Shafi Abdulsalam, Hari Chandana Ghanta, Prabu Pandurangan, Maya Menon, Sheba S.K. Jacob. A CASE OF ERYTHRODERMA SECONDARY TO HYPEREOSINOPHILIA. Journal of Clinical and Diagnostic Research [serial online] 2016 May [cited: 2018 Jan 18 ]; 10:OD15-OD16. Available from
Date of Submission: Jan 24, 2015
Date of Peer Review: Feb 23, 2016
Date of Acceptance: Mar 11, 2016
Date of Publishing: May 01, 2016
Financial OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)